Zueva E P, Naumova E M, Valentinov B G, Amosova E N, Razina T G, Krylova S G, Shilova N V, Gol'dberg V E
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Bull Exp Biol Med. 2000 Dec;130(12):1150-2.
Bioactive additive mammoleptin used for the treatment of fibrocystic breast disease did not stimulate the growth of primary tumors and metastases in mice with transplanted tumors. Mammoleptin in high doses inhibited the growth of Ehrlich adenocarcinoma and metastatic spreading of solid tumors.
用于治疗乳腺纤维囊性疾病的生物活性添加剂乳腺瘦素不会刺激移植肿瘤小鼠的原发性肿瘤生长和转移。高剂量的乳腺瘦素可抑制艾氏腺癌的生长和实体瘤的转移扩散。